What Are the Benefits of New Injectable Cell Therapy for Osteoarthritis?
The cell therapy tested in a pre-clinical model has the ability to undo cartilage damage in the synovial membrane and reduce joint inflammation.
Source: medindia.net
Page 27 - Oint Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Oint Inflammation Today - Breaking & Trending Today
Pediatric Crohn's: Adalimumab+Methotrexate Offers Strong Benefit
A landmark trial suggests adding low-dose methotrexate should be strongly considered in children with Crohn's disease who are starting adalimumab.
Source: medscape.com
Answers Sought for Mental Health Needs in Pediatric Rheumatology
One study found a tremendous increase in screening by automating the process while another found remote delivery of a 6-week cognitive behavioral program to improve mood and pain symptoms.
Source: medscape.com
DMARDs Taper-to-Discontinuation Trial Deemed Inconclusive
For patients with RA in sustained remission taking half doses of conventional synthetic DMARDs, the risk of flare was similar to that from stopping medication altogether, but the trial was too small to inform practice.
Source: medscape.com
FDA Approves New Formulation of Hyrimoz Adalimumab Biosimilar
The agency approved a higher concentration formulation of Hyrimoz for its previous indications, including rheumatoid arthritis and psoriasis.
Source: medscape.com